Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Asset Writedowns and Impairment: 2013-2016

Historic Asset Writedowns and Impairment for Amphastar Pharmaceuticals (AMPH) over the last 1 years, with Jun 2016 value amounting to $114,000.

  • Amphastar Pharmaceuticals' Asset Writedowns and Impairment was N/A to $114,000 in Q2 2016 from the same period last year, while for Jun 2016 it was $463,000, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2023, which is N/A change from last year.
  • Amphastar Pharmaceuticals' Asset Writedowns and Impairment amounted to $114,000 in Q2 2016, which was down 47.47% from $217,000 recorded in Q1 2016.
  • Amphastar Pharmaceuticals' Asset Writedowns and Impairment's 5-year high stood at $217,000 during Q1 2016, with a 5-year trough of $4,000 in Q3 2015.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Asset Writedowns and Impairment value was $121,000 (recorded in 2015), while the average stood at $112,750.
  • The largest annual percentage gain for Amphastar Pharmaceuticals' Asset Writedowns and Impairment in the last 5 years was 64.10% (2015), contrasted with its biggest fall of 69.23% (2015).
  • Quarterly analysis of 4 years shows Amphastar Pharmaceuticals' Asset Writedowns and Impairment stood at $120,000 in 2013, then crashed by 35.00% to $78,000 in 2014, then skyrocketed by 64.10% to $128,000 in 2015, then reached $114,000 in 2016.
  • Its Asset Writedowns and Impairment was $114,000 in Q2 2016, compared to $217,000 in Q1 2016 and $128,000 in Q4 2015.